Bio

David Shin is a Director on the Investment and Research Team at DRI Healthcare and is responsible for diligence on deal opportunities. David has over 6 years of experience in drug development, commercialization, and reimbursement. Prior to joining DRI Healthcare, David worked as a Health Economist at BC Cancer where he conducted health technology assessments and developed managed access strategies for emerging technologies in precision oncology. David also worked at Analysis Group supporting drug development and reimbursement efforts for Fortune 500 biopharmaceutical companies and at Admare Bioinnovations supporting project management and R&D operations for pre-clinical assets. David holds a MSc in Population and Public Health and a BSc (Hons.) in Biotechnology from the University of British Columbia.